Reference
US FDA. Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination. Internet Document : 13 Sep 2021. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jacobus-pharmaceutical-company-inc-issues-voluntary-worldwide-recall-ruzurgir-amifampridine-10-mg
Rights and permissions
About this article
Cite this article
Recall of amifampridine tablets due to contamination. Reactions Weekly 1874, 1 (2021). https://doi.org/10.1007/s40278-021-02658-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-02658-z